Purpose of this Study
We are doing this study to research the genes of patients with lung cancer that has been or will be removed by surgery for a chance to get treatment in a clinical trial.
Who Can Participate?
Eligibility
Adults 18 years and older who:
- Have lung cancer that has been removed by surgery or can be removed by surgery
- Have not received chemotherapy or radiation before surgery
- Are not pregnant
- Do not have recurrent lung cancer
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, you will:
- Answer questionnaires
- Have blood draws
- Have tissue samples taken
- Possibly be eligible to join another clinical trial, depending on the results of your genetic testing
- Be contacted by the study team every 6 months for 5 years
Locations
Duke University Hospital
Duke Raleigh Hospital
Other
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
Alliance A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Principal Investigator
Jeffrey
Crawford
Protocol Number
PRO00057971
NCT ID
NCT02194738
Phase
N/A
Enrollment Status
Open to Enrollment